BridgeBio Pharma, Inc. Peo Total Comp Amt
BridgeBio Pharma, Inc. (BBIO) reported Peo Total Comp Amt of $14.94 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-24.
Financial Statements › Notes
ecd:PeoTotalCompAmt · last filed 2026-04-24
| Period end | Peo Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $14.94M DEF 14A · filed 2026-04-24 |
| 2024-12-31 | $15.58M DEF 14A · filed 2026-04-24 |
| 2023-12-31 | $12.16M DEF 14A · filed 2026-04-24 |
| 2022-12-31 | $6.67M DEF 14A · filed 2026-04-24 |
| 2021-12-31 | $25.63M DEF 14A · filed 2026-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |